Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK
- 1 January 2005
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 23 (8) , 777-790
- https://doi.org/10.2165/00019053-200523080-00004
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Parent Report Form of the CHIP–Child EditionMedical Care, 2004
- Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory IssuesValue in Health, 2004
- Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response StudyPediatrics, 2001
- Measurement of Health Outcomes in Treatment Effectiveness EvaluationsMedical Care, 2000
- Recommendations for Evaluating the Validity of Quality of Life Claims for Labeling and PromotionValue in Health, 1999
- EuroQol: the current state of playHealth Policy, 1996
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Epidemiology and Course of Psychiatric Disorders in School‐Age Children—Results of a Longitudinal StudyJournal of Child Psychology and Psychiatry, 1990
- Utilities and Quality-Adjusted Life YearsInternational Journal of Technology Assessment in Health Care, 1989
- Measurement of health state utilities for economic appraisalJournal of Health Economics, 1986